Infographic: Changes in amphetamine residues from wastewater analyses in 29 European cities during the first lockdown period compared with before the pandemic (left) and after the first lockdown period (right)

Originally published in:

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
Figure 9, page 13

Main subject

prevalence and patterns of drug use

Keywords

amphetamine
COVID-19
methodology
prevalence and patterns of drug use
trendspotter study
wastewater analysis

Target audience

policymaker
researcher

Media type:

infographics

Published date:

April 2021
CC-BY-4.0
Download (0.19 MB)

Related assets in the Media library

screenshot from video
EMCDDA webinar recording: How wastewater monitoring can boost preparedness for new health threats
Cannabis users are the most likely to report using more than one drug other than their primary drug, followed by opioids and cocaine users.
Infographic: polydrug use among clients entering treatment by primary drug in the EU-27, Norway and Turkey, 2020
Map showing estimates of prevalence of high risk opioid use in Europe. Rates range from below 1 to around 8 per 1000.
Last year prevalence of high-risk opioid use among adults in Europe
Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%
At a glance — estimates of drug use in the European Union (updated June 2022)
Infographics: Changes in the mean weekly amounts of methamphetamine residues from wastewater analyses in selected European cities between 2019 and 2020
Infograpic: Proportion of all amphetamine samples submitted for testing to drug-checking services containing only the expected substance (amphetamine) in nine European cities in 2019 and 2020

Media library

Loading